fremtidbio.

ABOUT FREMTIDBIO

A future where
infections remain
treatable.

That is the future we work towards. We believe progress against antimicrobial resistance starts by connecting disciplines—and asking better questions at every stage of discovery.

Meet the team
OUR NAME. OUR PURPOSE.

fremtid.

Norwegian for “future”

A shared purpose.
Different scientific perspectives.

OSLO, NORWAY

Connecting disciplines.
Opening possibilities.

Fremtid Bio AS is a biotechnology company based in Oslo, Norway. We bring computational insight and high-throughput experiments together to explore new antimicrobial peptides and small molecules.

Our goal is to turn biological understanding into better possibilities for treatment. By combining AI, bioinformatics and experimental science, we build a discovery process in which each result informs the next question.

Explore our pipeline

Different expertise.
One shared ambition.

Molecular biology, bioinformatics and drug discovery.
Connected by a commitment to better science.

Dr. Amit Sharma

Molecular & cell biology

Dr. Amit Sharma

Molecular biology PhD · NTNU, Norway

Combines expertise in proteomics and molecular diagnostics with experience in genetic engineering, cell-based studies and assay development.

LinkedIn
Dr. Sajan Raju

Bioinformatics & microbiomes

Dr. Sajan Raju

Bioinformatics PhD · University of Helsinki, Finland

Works across omics and microbiome research, using metagenomic analysis to investigate questions in human health and environmental biology.

LinkedIn
Dr. Siva Krishna Vagolu

Computational drug discovery

Dr. Siva Krishna Vagolu

Pharmacy PhD · BITS Pilani, Hyderabad, India

Connects computational drug discovery with experimental research and omics, with a focus on antimicrobial resistance and cancer therapeutics.

LinkedIn
Dr. Yanwu Guo

Molecular biology & omics

Dr. Yanwu Guo

Epigenetics PhD · Institute of Biochemistry and Biophysics, Polish Academy of Sciences

Brings together molecular biology, bioinformatics and the analysis of omics data to explore biological questions.

LinkedIn

Good science starts
with a conversation.

We welcome research collaborations and discovery partnerships with people who share our ambition to advance antimicrobial research.

Start a conversation